Po-Yuan Chen

Dr. Po-Yuan Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in Medicina
Verified
Journal Article
Open access
PDF file
WWWilliam Winardi
William Winardi
SMSin Hua Moi
Sin Hua Moi
TWThomas Winardi
Thomas Winardi
YCYuWen Cheng
YuWen Cheng
PCPo-Yuan Chen
Po-Yuan Chen
CLCheng-Kai Lin
Cheng-Kai Lin
Background and Objectives: Although statins are recommended for secondary prevention of acute ischemic stroke, some population-based studies and clinical evidence suggest that they might be used with an increased risk of intracranial hemorrhage. In this nested case–control study, we used Taiwan’s nationwide universal health insurance database to investigate the possible association between statin therapy prescribed to acute ischemic stroke patients and their risk of subsequent intracerebral hemorrhage and all-cause mortality in Taiwan. Materials and Methods: All data were retrospectively obtained from Taiwan’s National Health Insurance Research Database. Acute ischemic stroke patients were divided into a cohort receiving statin pharmacotherapy and a control cohort not receiving statin pharmacotherapy. A 1:1 matching for age, gender, and index day, and propensity score matching was conducted, producing 39,366 cases and 39,366 controls. The primary outcomes were long-term subsequent intracerebral hemorrhage and all-cause mortality. The competing risk between subsequent intracerebral hemorrhage and all-cause mortality was estimated using the Fine and Gray regression hazards model. Results: Patients receiving statin pharmacotherapy after an acute ischemic stroke had a significantly lower risk of subsequent intracerebral hemorrhage (p < 0.0001) and lower all-cause mortality rates (p < 0.0001). Low, moderate, and high dosages of statin were associated with significantly decreased risks for subsequent intracerebral hemorrhage (adjusted sHRs 0.82, 0.74, 0.53) and all-cause mortality (adjusted sHRs 0.75, 0.74, 0.74), respectively. Conclusions: Statin pharmacotherapy was found to safely and effectively reduce the risk of subsequent intracerebral hemorrhage and all-cause mortality in acute ischemic stroke patients in Taiwan.

19 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TCTzu-Ning Chen
Tzu-Ning Chen
JHJyun-Yuan Huang
Jyun-Yuan Huang
TCTe-Yuan Chen
Te-Yuan Chen
YWYu-Ying Wu
Yu-Ying Wu
PCPo-Yuan Chen
Po-Yuan Chen
HWHao-Kuang Wang
Hao-Kuang Wang
Background: Smoking is a well-established risk factor for acute ischemic stroke, but its influence on endovascular thrombectomy outcomes remains unclear. While previous studies suggested a “smoking paradox” in thrombolysis, evidence regarding EVT is limited. Methods: We conducted a prospective, single-center observational study of 169 patients with acute ischemic stroke who underwent EVT between January 2019 and March 2023, using data from a tertiary hospital thrombectomy database in Kaohsiung, Taiwan. Patients were categorized as smokers (n=52) or non-smokers (n=117). Baseline characteristics were adjusted using inverse probability of treatment weighting. The primary endpoint was complete reperfusion. Secondary outcomes included NIHSS scores at admission and 24 hours post-procedure, modified Rankin Scale at discharge, and complications. Results: Smokers were younger and more often male, with lower rates of atrial fibrillation. After IPTW adjustment, smokers had significantly lower rates of complete reperfusion compared to non-smokers (30% vs. 53%; OR 0.39; 95% CI 0.19–0.79; p=0.01). They also presented with higher NIHSS scores at admission and 24 hours post-thrombectomy (p<0.05), and an increased risk of stroke-associated pneumonia (OR 2.98; p=0.003). No significant difference in discharge mRS was observed. Conclusions: Smoking is associated with reduced reperfusion success, worse neurological status, and higher pneumonia risk after EVT, but not with short-term functional outcome. These findings contradict the notion of a smoking–reperfusion paradox in EVT-treated AIS patients.

11 May 2025
Verified
Book Chapter
Closed access
PDF file
PCPo-Yuan Chen
Po-Yuan Chen
KLKang Lu
Kang Lu
LYLee-Ren Yeh
Lee-Ren Yeh
JTJen-Wei Tsai
Jen-Wei Tsai
Chao-Tien HsuChao-Tien Hsu
Chao-Tien Hsu